PROTECT MULTI AKTIENANLEIHE - SANOFI/FRESENIUS/MERCK Stock

Certificat

DE000VU63CQ9

Delayed Deutsche Boerse AG 04:33:42 2024-05-29 EDT
100.1 EUR +0.02% Intraday chart for PROTECT MULTI AKTIENANLEIHE - SANOFI/FRESENIUS/MERCK
Current month+0.26%
1 month+0.52%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-29 100.1 +0.02%
24-05-28 100.1 -0.04%
24-05-27 100.1 +0.01%
24-05-24 100.1 -0.03%
24-05-23 100.1 -0.03%

Delayed Quote Deutsche Boerse AG

Last update May 29, 2024 at 04:33 am

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying MERCK KGAA
IssuerLogo Issuer Vontobel Vontobel
WKN VU63CQ
ISINDE000VU63CQ9
Date issued 2023-05-22
Strike 166.1
Maturity 2024-06-21 (24 Days)
Parity 0.17 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 103
Lowest since issue 91.51
Spread 5
Spread %0.50%

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
167.6 EUR
Average target price
183.6 EUR
Spread / Average Target
+9.49%
Consensus